Literature DB >> 893674

Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

H E Jasin.   

Abstract

A 56-yr-old black woman with absence of the eighth component of complement and a disease compatible with systemic lupus erythematosus is described. Her disease is characterized by the presence of photosensitive "malar" rash, alopecia, polyarthritis, and nephrotic syndrome. Hemolytic and immunochemical assays of the serum complement components were normal, except for C8 which was undetectable. Hemolytic activity could be restored to normal by the addition of functionally pure C8. In vitro tests to investigate the functional integrity of the classical and alternative pathways indicated that the functions mediated by activation of C3 and C5 were intact whereas heatlabile bactericidal activity was totally absent. Addition of C8 restored this function to normal levels. One of two brothers of the proband was shown to have serum C8 levels approaching 50% of normal indicating the hereditary nature of the defect. HLA typing studies showed that the normal brother had identical haplotypes to the proband while the proposed heterozygous brother only shared one haplotype with the patient, suggesting that the gene controlling the C8 defect was not closely linked to the major histocompatibility complex. If the association of a connective tissue disease and absence of a terminal component of complement is not coincidental, these results suggest that C8 deficiency may be associated with a subtle defect in the defense mechanisms to viral infection leading to viral persistance and perhaps to diseases such as systemic lupus erythematosus where chronic viral infections have been implicated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893674      PMCID: PMC372416          DOI: 10.1172/JCI108823

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  IMMUNE BACTERICIDAL ACTIVITY OF COMPLEMENT. SEPARATION AND DESCRIPTION OF INTERMEDIATE STEPS.

Authors:  K ROTHER; U ROTHER; K F PETERSEN; D GEMSA; F MITZE
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

Authors:  C B LAURELL
Journal:  Anal Biochem       Date:  1965-02       Impact factor: 3.365

3.  IN VIVO BEHAVIOR OF I-FIBRINOGEN.

Authors:  A S McFarlane
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

4.  Chromosome 6: linkage of the eighth component of complement (C8) to the histocompatibility region (HLA).

Authors:  A D Merritt; B H Petersen; A A Biegel; D A Meyers; G F Brooks; M E Hodes
Journal:  Cytogenet Cell Genet       Date:  1976

5.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

6.  The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement.

Authors:  D Raum; D Glass; C B Carpenter; C A Alper; P H Schur
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

7.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

8.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

9.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

2.  Genetic polymorphism of complement component C8.

Authors:  S Rogde; B Mevåg; P Teisberg; T Gedde-Dahl; F Tedesco; B Olaisen
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 3.  Inherited deficiencies of complement proteins in man.

Authors:  C A Alper; F S Rosen
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

Authors:  F Tedesco; P Densen; M A Villa; B H Petersen; G Sirchia
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

5.  Genetic polymorphism in C8 beta-chains. Evidence for two unlinked genetic loci for the eighth component of human complement (C8).

Authors:  C A Alper; D Marcus; D Raum; B H Petersen; T J Spira
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

6.  Inherited C8 beta subunit deficiency in a patient with recurrent meningococcal infections: in vivo functional kinetic analysis of C8.

Authors:  C P Rao; J O Minta; B Laski; C A Alper; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

7.  Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system.

Authors:  P Densen; E J Brown; G J O'Neill; F Tedesco; R A Clark; M M Frank; D Webb; J Myers
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

8.  SLE-like and sicca symptoms in late component (C9) complement deficiency.

Authors:  M Sugimoto; M Nishikai; A Sato; Y Suzuki; M Nihei; J Uchida; N Mimura
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

9.  Genetic control of the eighth component of complement.

Authors:  D Raum; M A Spence; D Balavitch; S Tideman; A D Merritt; R T Taggart; B H Petersen; N K Day; C A Alper
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

10.  Microarray-based identification of differentially expressed genes in families of turbot (Scophthalmus maximus) after infection with viral haemorrhagic septicaemia virus (VHSV).

Authors:  P Díaz-Rosales; A Romero; P Balseiro; S Dios; B Novoa; A Figueras
Journal:  Mar Biotechnol (NY)       Date:  2012-07-13       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.